Return of the lysergamides. Part II: Analytical and behavioural characterization of N6-allyl-6-norlysergic acid diethylamide (AL-LAD) and (2’S,4’S)-lysergic acid 2,4-dimethylazetidide (LSZ)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Elliott, S. P., Wallach, J., Colestock, T., ... & Halberstadt, A. L. | Drug testing and analysis | 6 June 2016

Human Pharmacology of Mephedrone in Comparison to MDMA

Papaseit, E., Pérez-Mañá, C., Mateus, J. A., Pujadas, M., Fonseca, F., Torrens, M., ... & Farré, M. | Neuropsychopharmacology | 20 May 2016

Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens

Rickly, A., Moning, O., Hoener, M., Liechti, M. | European Neuropsychopharmacology | 20 May 2016

Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat

Horsley, R. R., Lhotkova, E., Hajkova, K., Jurasek, B., Kuchar, M., & Palenicek, T. | Brain Research Bulletin | 4 May 2016

A systematic review of the effects of novel psychoactive substances ‘legal highs’ on people with severe mental illness

Gray, R., Bressington, D., Hughes, E., & Ivanecka, A. | Journal of Psychiatric and Mental Health Nursing | 1 April 2016

Return of the lysergamides. Part I: Analytical and behavioural characterization of 1-propionyl-d-lysergic acid diethylamide (1P-LSD)

Brandt, S. D., Kavanagh, P. V., Westphal, F., Stratford, A., Elliott, S. P., Hoang, K., ... & Halberstadt, A. L. | Drug Testing and Analysis | 12 October 2015

Salvinorin A, a kappa-opioid receptor (KOP-r) agonist hallucinogen: Pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

Butelman, E., & Kreek, M. J. | Frontiers in Pharmacology | 08 Sep 2015

The hallucinogenic world of tryptamines: an updated review

Araújo, A. M., Carvalho, F., de Lourdes Bastos, M., de Pinho, P. G., & Carvalho, M. | Archives of toxicology | 16 April 2015

Recreational Use, Analysis and Toxicity of Tryptamines.

Tittarelli, R., Mannocchi, G., Pantano, F., & Saverio Romolo, F. | Current Neuropharmacology | 13 January 2015

Dictyonema huaorani (Agaricales: Hygrophoraceae), a new lichenized basidiomycete from Amazonian Ecuador with presumed hallucinogenic properties

Schmull, M., Dal-Forno, M., Lücking, R., Cao, S., Clardy, J., & Lawrey, J. D. | The Bryologist | 7 November 2014

Michael acceptor approach to the design of new salvinorin A-based high affinity ligands for the kappa-opioid receptor

Polepally, P. R., Setola, V., Vardy, E., Roth, B. L., Mosier, P. D., & Zjawiony, J. | Planta Medica | 6 October 2014

Iboga-Type Alkaloids from Ervatamia officinalis

Tang, B. Q., Wang, W. J., Huang, X. J., Li, G. Q., Wang, L., Jiang, R. W., ... & Ye, W. C. | Journal of natural products | 5 August 2014

From PCP to MXE: a comprehensive review of the non-medical use of dissociative drugs

Morris, H., & Wallach, J. | Drug testing and analysis | 26 March 2014

Methoxetamine (MXE) – A Phenomenological Study of Experiences Induced by a “Legal High” from the Internet

Kjellgren, A., & Jonsson, K. | Journal of psychoactive drugs | 2 August 2013

2C or not 2C: phenethylamine designer drug review

Dean, B. V., Stellpflug, S. J., Burnett, A. M., & Engebretsen, K. M. | Journal of Medical Toxicology | 9 June 2013

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor

Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X. P., Setola, V., Treble, R., & Iversen, L. | PLoS One | 19 March 2013

Heaven and Hell—A Phenomenological Study of Recreational Use of 4-HO-MET in Sweden

Kjellgren, A., & Soussan, C.| Journal of Psychoactive Drugs | 29 August 2011

Comparative potencies of MDMA analogues as inhibitors of [3H]noradrenaline and [3H]5-HT transport in mammalian cell lines

Montgomery, T., Buon, C., Eibauer, S., Guiry, P. J., Keenan, A.K., & McBean, G. J. | British Journal of Pharmacology | December 2007

Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens

Nichols, D. E. | Journal of psychoactive drugs | 1 January 1986